04/01
Headlines

CLDX

Biotech bullish Stocks: ImmunoGen (NASDAQ:IMGN), OXiGENE Inc (NASDAQ:OXGN), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics (NASDAQ:CLDX)

Jayne Crisman02 mins

Shares of ImmunoGen Inc. (NASDAQ:IMGN), a biopharmaceutical company focused on developing therapies to fight cancer, advanced as much as 15% after research firm Canaccord Genuity initiated coverage on the company. ImmunoGen, Inc. (NASDAQ:IMGN) stock performance was 11.02% in last session and finished the day at $14.21. Traded volume was 2.85million shares in the last session…

Read More

Biotech Most Volatile: Celldex Therapeutics (NASDAQ:CLDX), Dyax Corp. (NASDAQ:DYAX), Insmed Incorporated (NASDAQ:INSM), Novavax (NASDAQ:NVAX)

Chris Lewis02 mins

Celldex Therapeutics Inc. (NASDAQ:CLDX) options contracts experienced a new 90-day record for call contracts where a total of 5,803 call contracts were traded in the busy trading session. The contract spread yielded a 0.58 put/call ratio where 1.7 call contracts were traded for each put contract. Celldex Therapeutics, Inc. (NASDAQ:CLDX) stock performance was 0.07% in…

Read More

Top Losers: Advanced Micro Devices (NYSE:AMD), Sprint Corporation (NYSE:S), Yingli Green Energy (NYSE:YGE), Celldex Therapeutics (NASDAQ:CLDX)

Adam Keintzel02 mins

Many sources from the GPU industry indicated last month that neither Advanced Micro Devices, Inc. (NYSE:AMD), nor Nvidia Corp. plan to make major GPU introductions at least till late in 2014, or maybe even early 2015. Advanced Micro Devices, Inc. (NYSE:AMD) stock performance was -5.19% in last session and finished the day at $3.65. Traded…

Read More

Biotech Losers: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Novavax, Inc. (NASDAQ:NVAX), Biogen Idec Inc (NASDAQ:BIIB)

Jayne Crisman02 mins

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and AstraZeneca (NYSE:AZN) are among those companies with late stage drugs in trials that specifically target genetic mutations. Both BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s BMN-673, which is in phase 3 trials, and Astra’s Olaparib, which may get the EU’s go-ahead in ovarian cancer this year, address a mutation of the BRCA 1…

Read More

Biotech Bearish Stocks: Questcor Pharmaceuticals (NASDAQ:QCOR), ACADIA Pharmaceuticals (NASDAQ:ACAD), Idera Pharmaceuticals (NASDAQ:IDRA), Celldex Therapeutics (NASDAQ:CLDX)

John Bellich02 mins

Citron exposes explosive findings behind the true components of Questcor Pharmaceuticals Inc (NASDAQ:QCOR) flagship drug HP Acthar Gel. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) stock performance was -9.96% in last session and finished the day at $60.75. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 2.86 million shares….

Read More

Must Watch These 5 Stocks: Energy XXI (NASDAQ:EXXI), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Qihoo 360 Technology (NYSE:QIHU), Ford Motor Company (NYSE:F), Geeknet (NASDAQ:GKNT)

Adam Keintzel02 mins

Energy XXI LTD (NASDAQ:EXXI) announced that James (Jim) LaChance and Norman (Norm) Louie have been named to its board of directors, increasing the size of the board to nine total, eight of whom are non-employee directors. The appointments were effective December 15, 2014 and both will stand for election by shareholders at the 2015 annual…

Read More